Transferring Vape Regulation Rights to FDA Urged by Filipino Health Official

Regulations by 2FIRSTS.ai
May.06.2024
Transferring Vape Regulation Rights to FDA Urged by Filipino Health Official
Philippine lawmaker Ray T. Reyes urges reevaluation of e-cigarette regulations due to rising lung diseases linked to vaping.

According to recent news from the Philippine Department of Public Health, AnaKalusugan Party-list representative Ray T. Reyes is urging other legislators to reconsider existing policies regulating the use of e-cigarette products, as there have been cases of lung-related illnesses associated with e-cigarette use.

 

Reyes calls for a thorough review of the Republic Act No. 11900 or the "Vaporized Nicotine and Non-Nicotine Products Regulation Act" and advocates for transferring the responsibility of regulating e-cigarette products from the Department of Trade and Industry (DTI) to the Food and Drug Administration (FDA).

 

For years, we have been warning everyone that placing e-cigarettes under the supervision of the Department of Trade and Industry (DTI) is a mistake. Two years have passed, and now we are seeing the consequences. We need to amend the IRR (Implementing Rules and Regulations) to return e-cigarette products to the Department of Health (DOH) and FDA, rather than the DTI.

 

Reyes cited a report from the Philippine College of Chest Physicians, which showed a significant increase in cases of e-cigarette/vaping-associated lung injury (EVALI) nationwide. He also referenced the latest Global Youth Tobacco Survey, which revealed that 14% (or one in seven) of Filipinos aged 13 to 15 are already using e-cigarettes.

 

It is concerning that an increasing number of young people in the Philippines are using e-cigarettes. We should redouble our efforts to enforce smoking and e-cigarette laws, especially those targeting minors.

 

According to data from the Philippine National Police, over 8,600 minors were arrested for violating e-cigarette and smoking laws from May to December 2023.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.